Acute kidney injury and Primary Aldosteronism
Research Field
Vin-Cent Wu, group director of Taiwan Primary Aldosteronism Investigation (TAIPAI) and the National Taiwan University Study Group on Acute Renal Failure (NSARF), is a Professor of Medicine with career-long research in acute kidney injury and primary aldosteronism, and nephrology while being an activist for translational medicine.
Vin-Cent actively involved in the analysis of the largest database of acute kidney injury in the (NSARF and Consortium for Acute Kidney Injury and Renal Diseases (CAKs) strive to advance high-quality care in acute kidney injury (AKI) and aspires to plunge the worldwide increasing prevalence of chronic kidney disease (CKD) from the perspective of AKI-CKD transition. I am the committee of acute Disease Quality Initiative (ADQI) and Kidney Disease: Improving Global Outcomes (KDIGO).
Vin-Cent conducts the TAIPAI database, which is the largest registry about primary aldosteronism in Chinese people. This project is to improve the diagnosis of aldosteronism and aldosterone-related cardiovascular, psychosocial morbidity and mortality.
my research contributions have been recognized by Stanford University, where I was honored as one of the top 2% scientists from the years 2020 to 2023.Throughout my journey in the field of Life Sciences, I have been fortunate to receive esteemed awards and honors, recognition for my exceptional research contributions.
An exceptional milestone in my career was achieving the Outstanding Research Award for Excellent Contribution in Medical Research at the National Taiwan University Hospital, which highlighted the significance of team research accomplishments. In 2022, I was awarded the Silver Medal of the Symbol of National Quality (SNQ) in recognition of my achievements. The award undergoes rigorous and professional scientific validation. I am honored to have been awarded the 2023 Professor Wan-Yu Chen Research Award by the Taiwan Society of Nephrology. In recent years, this award has come to symbolize a lifetime achievement in the field of nephrology in Taiwan.
My dedication to scholarly publishing extends to my role as an editor, where I am privileged to serve on the editorial boards and as an invited editor for esteemed journals. Through these affiliations, I contribute to the dissemination of groundbreaking research and foster meaningful discussions among peers in the scientific community.
- more than 170, about aldosteronism , including Hypertension and Lancet End Meta.
(https://pubmed.ncbi.nlm.nih.gov/?term=Wu+V%2C+aldosteronism&sort=date)
- more than 135, about AKI, including JASN, Intensive Care Medicine. Critical care, Diabetic Care, and JAMA NET OPEN.
(https://pubmed.ncbi.nlm.nih.gov/?term=Wu+V%2C+kidney+injury%2C+&sort=date)
My research contributions have been recognized by Stanford University, where I was honored as one of the top 2% scientists from the years 2020 to 2023.Throughout my journey in the field of Life Sciences, I have been fortunate to receive esteemed awards and honors, recognition for my exceptional research contributions.
An exceptional milestone in my career was achieving the Outstanding Research Award for Excellent Contribution in Medical Research at the National Taiwan University Hospital, which highlighted the significance of team research accomplishments. In 2022, I was awarded the Silver Medal of the Symbol of National Quality (SNQ) in recognition of my achievements. The award undergoes rigorous and professional scientific validation. I am honored to have been awarded the 2023 Professor Wan-Yu Chen Research Award by the Taiwan Society of Nephrology. In recent years, this award has come to symbolize a lifetime achievement in the field of nephrology in Taiwan.
- Division of Nephrology, Primary Aldosteronism Center (PAC) of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group
- NSARF (National Taiwan University Hospital Study Group of ARF), and CAKS (Taiwan Consortium for Acute Kidney Injury and Renal Diseases), Taipei, Taiwan
Job Description
Preferred Qualifications:
Education:
Senior undergraduate or graduate student (Master’s, MD, or PhD track) in Biomedical Sciences, Molecular Biology, Medicine, or a related field.
Skills & Experience:
Basic laboratory experience in cell biology or molecular techniques.
Familiarity with bioinformatics tools or pathway analysis (e.g., GEO2R, KEGG, Enrichr) is advantageous.
Proficiency in Microsoft Office, and basic statistical or plotting software (GraphPad Prism, R, or SPSS).
Strong written communication skills and attention to scientific detail.
Learning Opportunities:
Gain hands-on experience in translational molecular endocrinology and adrenal tumor biology.
Receive mentorship in manuscript preparation, data analysis, and academic writing.
Exposure to integrative omics approaches and clinical–molecular correlation within a multidisciplinary research team.
Preferred Intern Educational Level
Education Level:
Master’s student (MSc or MPH) or senior undergraduate in biomedical sciences, molecular biology, or medicine.
Alternatively, a medical student (3rd–5th year) with prior research or laboratory experience.
🧠 Core Knowledge Requirements:
Background in molecular or cellular biology, pathophysiology, or endocrinology.
Familiarity with basic laboratory techniques (cell culture, Western blotting, qPCR, IHC) and data interpretation.
Basic understanding of bioinformatics or transcriptomic data analysis is highly desirable.
💻 Technical Skills (preferred but trainable):
Competence in R or Python for data visualization and pathway analysis.
Experience with databases such as GEO or KEGG, and basic statistics (SPSS, GraphPad, or R).
Knowledge of histopathology terminology (APA, MAPN, etc.) is advantageous.
🧩 Research Qualities:
Analytical mindset and attention to detail.
Ability to synthesize multidisciplinary data (molecular, clinical, and imaging).
Strong written and verbal communication skills for figure legends, results summaries, and manuscript support.
🤝 Role in the Project:
Assist in data curation, figure generation, and reference organization.
Participate in validation experiments or literature synthesis.
Support statistical analysis and manuscript preparation.
Skill sets or Qualities
1. Integrative Translational Research Design
Combined clinical phenotyping, histopathology, genomics, and functional assays to link molecular mechanisms with patient outcomes.
Demonstrates the ability to bridge bench-to-bedside research in endocrine oncology.
2. Advanced Histopathologic Classification and Interpretation
Applied the HISTALDO system to stratify adrenal lesions, showing expertise in adrenal pathology and morphologic quantification.
Integrated histology with molecular features to define clinically meaningful subtypes.
3. Molecular and Genetic Profiling Expertise
Performed targeted next-generation sequencing to identify PA- and CS-related driver mutations (KCNJ5, PRKACA, GNAS).
Executed transcriptomic and pathway enrichment analyses (e.g., KEGG) to interpret biological programs at the systems level.
4. Bioinformatics and Data Integration
Synthesized histopathological, transcriptomic, and mutation data to construct a coherent mechanistic model.
Validated findings using public GEO datasets, demonstrating proficiency in secondary data analysis and reproducibility.
5. Functional and Mechanistic Validation
Conducted cell-based assays (HAC15 line) to confirm the causal role of DRD2 signaling in cortisol biosynthesis.
Utilized pharmacologic and genetic perturbation (agonist, antagonist, siRNA) to establish mechanistic causality.
6. Quantitative and Statistical Rigor
Applied appropriate nonparametric tests, correlation analyses, and standardized outcome definitions (PASO consensus).
Ensured methodological reproducibility and statistical transparency.
7. Translational and Clinical Insight
Linked molecular signatures to surgical outcomes and clinical phenotypes, highlighting translational impact.
Proposed dopaminergic signaling as a potential therapeutic target, bridging molecular endocrinology and patient care.
8. Scholarly Writing and Conceptual Synthesis
Demonstrates clear articulation of complex data within a cohesive mechanistic framework.
Balances molecular discovery with clinical interpretation — a hallmark of high-impact translational work.